OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
Hao Zhang, Shuangli Zhu, Haiting Zhou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 28
Hao Zhang, Shuangli Zhu, Haiting Zhou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 112
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 112
Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers
Wei Sun, Ruochen Liu, Xinyue Gao, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Wei Sun, Ruochen Liu, Xinyue Gao, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Ferroptosis: the emerging player in remodeling triple-negative breast cancer
Jie Li, Dejiao He, Sicheng Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Jie Li, Dejiao He, Sicheng Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Nanoparticles (NPs)-mediated targeted regulation of redox homeostasis for effective cancer therapy
Zixuan Zhao, Yuan Cao, Rui Xu, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 291-320
Open Access | Times Cited: 8
Zixuan Zhao, Yuan Cao, Rui Xu, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 291-320
Open Access | Times Cited: 8
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Kasra Mokhtarpour, Sepideh Razi, Nima Rezaei
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 497-513
Closed Access | Times Cited: 7
Kasra Mokhtarpour, Sepideh Razi, Nima Rezaei
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 497-513
Closed Access | Times Cited: 7
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Tangeretin regulates oxidative stress in cutaneous melanoma cells via the Nrf2 signaling pathway
Yuepeng An, Qing Zhang, Jing Zhao, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Yuepeng An, Qing Zhang, Jing Zhao, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells
Oleg Shuvalov, Yulia Kirdeeva, Elizaveta Fefilova, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 656-656
Open Access | Times Cited: 12
Oleg Shuvalov, Yulia Kirdeeva, Elizaveta Fefilova, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 656-656
Open Access | Times Cited: 12
Targeted nanoparticle delivery system for tumor-associated macrophage reprogramming to enhance TNBC therapy
Xiaoshen Dong, X. Wang, Xinyu Zheng, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Xiaoshen Dong, X. Wang, Xinyu Zheng, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Phosphorylation of eIF2α suppresses the impairment of GSH/NADPH homeostasis and mitigates the activation of cell death pathways, including ferroptosis, during ER stress
Lê Thị Thu Hiền, Yong Hwan Kim, Mi Jeong Kim, et al.
Molecules and Cells (2025), pp. 100210-100210
Open Access
Lê Thị Thu Hiền, Yong Hwan Kim, Mi Jeong Kim, et al.
Molecules and Cells (2025), pp. 100210-100210
Open Access
Iron-Dependent Cell Death: Exploring Ferroptosis as a Unique Target in Triple-Negative Breast Cancer Management
L. Tan, Jiaxing Liu, C Ma, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 625-637
Open Access
L. Tan, Jiaxing Liu, C Ma, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 625-637
Open Access
Theranostic Potential of Copper-64 ATSM Targeting MTHFD2: An In Silico Perspective on Hypoxia-Selective Imaging and Therapy
Abdulsalam Abuelsamen, Maram B. Alhawarri, Mohammad G. Al‐Thiabat, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Abdulsalam Abuelsamen, Maram B. Alhawarri, Mohammad G. Al‐Thiabat, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)
Leyu Ai, Na Yi, Chunhan Qiu, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 3
Leyu Ai, Na Yi, Chunhan Qiu, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 3
Construction and Analysis of a Mitochondrial Metabolism-Related Prognostic Model for Breast Cancer to Evaluate Survival and Immunotherapy
Yuting Lin, Zhongxin Huang, Baogen Zhang, et al.
The Journal of Membrane Biology (2024) Vol. 257, Iss. 1-2, pp. 63-78
Closed Access | Times Cited: 2
Yuting Lin, Zhongxin Huang, Baogen Zhang, et al.
The Journal of Membrane Biology (2024) Vol. 257, Iss. 1-2, pp. 63-78
Closed Access | Times Cited: 2
Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression
Xiaoliang Mo, Qianqian Liu, Kunling Liang, et al.
Journal of Bioenergetics and Biomembranes (2024) Vol. 56, Iss. 3, pp. 333-345
Closed Access | Times Cited: 2
Xiaoliang Mo, Qianqian Liu, Kunling Liang, et al.
Journal of Bioenergetics and Biomembranes (2024) Vol. 56, Iss. 3, pp. 333-345
Closed Access | Times Cited: 2
Nuclear factor erythroid 2-related factor-mediated signaling alleviates ferroptosis during cerebral ischemia-reperfusion injury
Zheng Li, Jihong Xing
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117513-117513
Open Access | Times Cited: 2
Zheng Li, Jihong Xing
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117513-117513
Open Access | Times Cited: 2
Ferroptosis and Triple-Negative Breast Cancer: A Systematic Overview of Prognostic Insights and Therapeutic Potential
Mohsin Khan, Vyshnavidevi Sunkara, Mansi Yadav, et al.
Cureus (2024)
Open Access | Times Cited: 1
Mohsin Khan, Vyshnavidevi Sunkara, Mansi Yadav, et al.
Cureus (2024)
Open Access | Times Cited: 1
STIL facilitates the development and malignant progression of triple-negative breast cancer through activation of Fanconi anemia pathway via interacting with KLF16
Meiling Wang, Bo Pan, Ye Hu, et al.
Translational Oncology (2024) Vol. 46, pp. 102010-102010
Open Access | Times Cited: 1
Meiling Wang, Bo Pan, Ye Hu, et al.
Translational Oncology (2024) Vol. 46, pp. 102010-102010
Open Access | Times Cited: 1
MMP9 Drives Ferroptosis by Regulating GPX4 and Iron Signaling
Flobater I. Gawargi, Paras K. Mishra
iScience (2024) Vol. 27, Iss. 9, pp. 110622-110622
Open Access | Times Cited: 1
Flobater I. Gawargi, Paras K. Mishra
iScience (2024) Vol. 27, Iss. 9, pp. 110622-110622
Open Access | Times Cited: 1
Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment
Nanyang Zhou, Dejia Kong, Qiao Lin, et al.
Cancer Genetics (2023) Vol. 276-277, pp. 17-29
Closed Access | Times Cited: 3
Nanyang Zhou, Dejia Kong, Qiao Lin, et al.
Cancer Genetics (2023) Vol. 276-277, pp. 17-29
Closed Access | Times Cited: 3
Lipid Peroxidation of the Docosahexaenoic Acid/Arachidonic Acid Ratio Relating to the Social Behaviors of Individuals with Autism Spectrum Disorder: The Relationship with Ferroptosis
Kunio Yui, George Imataka, Tadashi Shiohama
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14796-14796
Open Access | Times Cited: 3
Kunio Yui, George Imataka, Tadashi Shiohama
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14796-14796
Open Access | Times Cited: 3
Identification of MTHFD2 as a Prognostic Factor and Evaluation of its Role in Macrophage Polarization in Kidney Renal Clear Cell Carcinoma by Pan-Cancer Analysis
Yang Zhou, Xinmin Zheng, Penghui Ye, et al.
Research Square (Research Square) (2024)
Open Access
Yang Zhou, Xinmin Zheng, Penghui Ye, et al.
Research Square (Research Square) (2024)
Open Access
Establishment and validation of a prognostic scoring model based on disulfidptosis-related long non-coding RNAs in stomach adenocarcinoma
Weiming Xing, Shikai Xu, Hao Zhang
Translational Cancer Research (2024) Vol. 13, Iss. 5, pp. 2357-2371
Open Access
Weiming Xing, Shikai Xu, Hao Zhang
Translational Cancer Research (2024) Vol. 13, Iss. 5, pp. 2357-2371
Open Access
Joint Screening and Identification of Potential Targets of Nitazoxanide by Affinity Chromatography and Label-Free Techniques
Menghan Zhu, Dongxia Qi, Dongliang Chen, et al.
Current Drug Targets (2024) Vol. 25, Iss. 12, pp. 819-845
Closed Access
Menghan Zhu, Dongxia Qi, Dongliang Chen, et al.
Current Drug Targets (2024) Vol. 25, Iss. 12, pp. 819-845
Closed Access
VMA21: unveiling a novel oncogene that facilitates immune evasion in triple-negative breast cancer through TCIRG1 protein stability regulation
Xiangyang Guo, Zhiqiang Chen, Yongmin Miao, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 8, pp. 4096-4111
Closed Access
Xiangyang Guo, Zhiqiang Chen, Yongmin Miao, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 8, pp. 4096-4111
Closed Access
